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Malaria is a serious parasitic disease from tropical 
regions caused by a species of Plasmodium and trans-
mitted by Anopheles mosquitoes. It is prevalent in ap-
proximately 100 countries in Africa, Southeast Asia and 
South America, where approximately 2.4 million people 
are at risk (Kager 2002). According to the World Malaria 
Report (WHO 2009a), there are approximately 250 mil-
lion malaria cases and approximately one million people 
die from malaria each year.
The emergence and rapid spread of multidrug-resis-
tant strains of Plasmodium, particularly Plasmodium 
falciparum, represent a major problem for prophylaxis 
and treatment, which becomes more difficult and limits 
the choice of drugs used. This has been identified as the 
current primary cause of control failure.
The well-known use of chloroquine (CQ) and anti-
folates [sulfadoxine-pyrimethamine (S/P)] for malaria 
treatment are no longer effective in most endemic areas. 
Combination therapy has emerged as the best practical 
solution in overcoming the resistance of select strains. 
Therapeutics based on combinations with artemisinin 
and derivatives (ACTs), recommended by the World 
Health Organization (WHO), presently represent the 
most effective treatment of P. falciparum malaria infec-
tion (WHO 2008). Clinical resistance to these combina-
tions has been recently reported in Cambodia (Noedl et 
al. 2008), suggesting that P. falciparum parasites have 
already developed the ability to grow in the presence of 
these antimalarials, which strongly suggests the need for 
further research into new antimalarials.
There is broad consensus on the urgent need for new, 
affordable and efficient compounds that could serve as 
primary molecules for antimalarial treatment. New high-
ly-effective antimalarial drug candidates, based on new 
mechanisms of action or with new structures, are urgent-
ly needed to overcome the problem of rapid emergence of 
drug resistance and achieve long-term clinical efficacy.
Due to the crucial role that plant-derived compounds 
have played in drug discovery and development for the 
treatment of several diseases, the isolation of new bioac-
tive compounds from medicinal plants based on traditional 
use or ethnomedical data appears to be a very promising 
approach (Newman 2008, Turschner & Efferth 2009).
There is a consensus among the scientific commu-
nity that natural products have a dominant presence 
in discovering new leads for the development of drug 
treatment for human diseases. In fact, of the 877 novel 
medicines that were developed in the period between 
1981-2002, 6% were natural products, 27% were deriva-
tives of natural products and 16% were synthetics devel-
oped based on a natural product (Newman et al. 2003). 
At least 80% of the world population is estimated to be 
continuing use of such traditional medicines in primary 
health care, including 40,000-70,000 medicinal plants, 
approximately 20% of all higher-plant species (Ver-
poorte et al. 2006). In most cases, very little is known 
about the plants used in folk medicines.
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The isolation of bioactive compounds from medicinal plants, based on traditional use or ethnomedical data, is 
a highly promising potential approach for identifying new and effective antimalarial drug candidates. The purpose 
of this review was to create a compilation of the phytochemical studies on medicinal plants used to treat malaria in 
traditional medicine from the Community of Portuguese-Speaking Countries (CPSC): Angola, Brazil, Cape Verde, 
Guinea-Bissau, Mozambique and São Tomé and Príncipe. In addition, this review aimed to show that there are sev-
eral medicinal plants popularly used in these countries for which few scientific studies are available. The primary 
approach compared the antimalarial activity of native species used in each country with its extracts, fractions and 
isolated substances. In this context, data shown here could be a tool to help researchers from these regions establish 
a scientific and technical network on the subject for the CPSC where malaria is a public health problem.
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In malaria therapy, 11 drugs out of the antimalarials 
included in WHO therapeutic schemes for malaria treat-
ment are natural products or their analogues or were de-
sign-based on the pharmacophores from natural products 
(Bourdy et al. 2008). The great significance of plant-de-
rived drugs for the treatment of the disease is highlighted 
by quinine (derived from Cinchona tree), artemisinin 
(derived from Artemisia annua) and atovaquone (Ma-
larone®), which is a synthetic compound (2-alkyl-3-hy-
droxynaphthoquinone) analogue of lapachol from the 
Tabebuia species (Bignoniaceae) (Oliveira et al. 2009).
This review was based on compilation of medicinal 
plants used in traditional medicine in the treatment of 
malaria infections in some countries of the Commu-
nity of Portuguese-Speaking Countries (CPSC), which 
includes Angola, Brazil, Cape Verde, Guinea-Bissau, 
Mozambique and São Tomé and Príncipe (STP) and in-
volved the comparison of popularly used native species 
and studies on the antimalarial activity of extracts, frac-
tions and isolated substances.
The areas included in the CPSC are, to different de-
grees, developing nations where large fragments of the 
population have limited access to the National Health 
System. Consequently, these segments of the population 
use traditional medicine and their by products for ther-
apy. This pattern is clearly observed in Africa. There 
is a large body of literature from studies in Africa, but 
they are from different time periods and, in some cases, 
references to malaria may be read as anti-fever. Due 
to the differences in methods, models or assays used, 
not all of the information is comparable. This review is 
intended to be useful for establishing networks aimed 
at training, data comparison, standardisation of tech-
niques, incorporation of ethical issues into research 
and development activities and development of a web-
site for the CPSC.
In this context, a selection of the botanical species 
used as antimalarials that are native to the CPSC is sum-
marised, at the family level, in Fig. 1.
Fig. 1 shows the correlation between 21 botanical 
families and the CPSC. Analysis of this figure indicates 
that seven families (Apocynaceae, Asteraceae, Cucur-
bitaceae, Fabaceae, Meliaceae, Myristicaceae and Pi-
peraceae) have species commonly used by the CPSC to 
treat malaria. The Euphorbiaceae, Rubiaceae and So-
lanaceae families are represented by botanical species 
used primarily within African countries. Further, there 
are reports of other families of plants restricted to some 
countries: Angola (Annonaceae and Cochlospermace-
ae), Guinea-Bissau (Combretaceae and Hypencaceae) 
and Brazil have the most references to species belonging 
to the seven botanical families. Important correlations 
between each family, country, studied species, tested 
parts and scientific data from vitro and in vivo research 
are also provided in Table.
Brazil - In Brazil, malaria remains endemic in the 
Amazon, with a mortality of 58 patients out of 306,000 
cases per year, largely due to late diagnosis, inadequate 
treatment or multidrug-resistant parasites. This acute 
disease presents with typical symptoms (e.g., headache 
and recurrent fever) and individuals affected by malaria 
in endemic areas often self-medicate with available anti-
malarial drugs or medicinal plants.
Three Plasmodium species occur in humans in Bra-
zil: P. falciparum, the most deadly species; Plasmodium 
vivax, the most prevalent species, causing approximately 
80% of the current cases, according to the Ministry of 
Health reports, and Plasmodium malariae, the least-
prevalent species (Krettli et al. 2001). 
There are several studies reporting exotic and native 
species used popularly in Brazil for the treatment of fever 
and malaria (Brandão et al. 1992, Milliken 1997, Oliveira 
et al. 2003, Botsaris 2007, Mariath et al. 2009). Other re-
views have focused primarily on the in vitro antimalarial 
activity of alkaloids, discussing the different chemical 
classes and structure-activity relationship. �nfortunate-
ly, most of these compounds were not evaluated in vivo.
The application of ethnopharmacology in selecting 
plants with antimalarial uses represents a reasonable ap-
proach for identifying new drugs. In fact, in vivo pharma-
cological evaluation of 22 plants used by popular medi-
cine in Brazil identified four plant species with activity 
against Plasmodium berghei in mice. The active plants 
were: Esenbeckia febrifuga (Rutaceae), Lisianthus spe-
ciosus (Gentianaceae), Acanthospermum australe (Com-
positae) and Tachia guyanensis (Gentianaceae) (Brandão 
et al. 1992). Among the 273 species tested based on ran-
dom selection, only two, which represents 0.7%, exhibit-
ed activity: Vernonia brasiliana (Compositae) and Eupa-
torium squalidum (Compositae) (Brandão et al. 1992). In 
another study, 204 extracts were tested from Brazilian 
Cerrado plants, of which 32 (15.7%) showed significant 
parasite growth inhibition at 10 µg/mL. The most active 
families exhibited IC50 values ranging from 0.9 µg/mL 
(Flacourtiaceae and Sapindaceae) to 4.9 µg/mL (Apocy-
naceae and Annonaceae) (de Mesquita et al. 2007).
Extracts and active compounds from native species 
in Brazil that exhibited antimalarial activity are shown 
in Table. The most active species used in different Bra-
zilian regions are described below.
Fig. 1: distribution of plant families studied as antimalarial among 
Community of Portuguese-Speaking Countries. 
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Bidens pilosa (Asteraceae), popularly known as picão 
and picão preto in Brazil, is a species with extensive eth-
nopharmacological use (de Andrade-Neto et al. 2004). 
The popular use as an antimalarial was substantiated the 
crude ethanol extract of the whole plant, leaves and roots 
at concentrations of 25-50 µg/mL. Pharmacological ac-
tivity was attributed to the presence of polyacetylene and 
flavonoids (Brandão et al. 1997), which was reinforced 
by data from Oliveira et al. (2004) correlating these sub-
stances with in vivo antimalarial activity. 
A recent review on Ampelozizyphus amazonicus 
(Rhamnaceae), popularly called as cervejeira, cerveja 
de índio, saracura, curupira-mirá and saracura-mirá, 
summarised the importance of this native species as an 
antimalarial in endemic areas (Amaral et al. 2008). Al-
though the prophylactic activity of the crude ethanol ex-
tract from the roots of this plant has been proven (Krettli 
et al. 2001, de Andrade-Neto et al. 2008), the mechanism 
of action and the active substances of A. amazonicus 
have not yet been identified. 
Some botanical species used in folk phytotherapy in 
Brazil against malaria are known as quinas, for exam-
ple, Deianira erubescens, Strychnos pseudoquina and 
Remijia ferruginea (de Andrade-Neto et al. 2003). In this 
context, ethanol extract from R. ferruginea (Rubiaceae) 
bark, popularly known as quina-da-serra or quina-do-
Brasil, when evaluated against P. berghei, caused inhibi-
tion of up to 48% of parasite growth at a dose of 1,000 
mg/kg but exhibited only minimal activity at the lower 
dose of 500 mg/kg (de Andrade-Neto et al. 2003).
Casearia sylvestris (Flacourtiaceae) is a plant popu-
larly known as guaçatonga and antiplasmodial activity 
was found with extracts of different parts of this plant, 
with IC50 values ranging from 0.9 (stem wood) to 2.3 µg/
mL (root wood) (de Mesquita et al. 2007). 
The Virola surinamensis tree frequently grows on 
Amazonian riverbanks and is used in folk medicine for 
a variety of ailments. The Waiãpi Indians treat malaria 
with this species by inhalation of vapour prepared from 
leaves of the plant. The essential oil of the leaves (100 µg/
mL) causes 100% inhibition in growth from the young 
trophozoite to schizont development stages and the ses-
quiterpenoid nerolidol (half of the oil dose) was identi-
fied as one of the active compounds (Lopes et al. 1999).
Mozambique - In Mozambique, malaria is the leading 
cause of morbidity and mortality, accounting for a third 
of all hospital deaths (�SAID 2009). It is estimated that 
approximately 44,000-67,000 deaths are attributable to 
malaria each year (MH 2003). Approximately 9.8 million 
malaria cases were reported in 2006 (WHO 2009b).
Disease transmission is stable and the presence of the 
disease is endemic throughout the country due to unaf-
fordable preventive means, favourable temperatures and 
rain patterns, abundant breeding sites and poverty-relat-
ed improper housing (Mabunda 2006).
This high prevalence of CQ-resistant (CQR) P. fal-
ciparum strains has been reported throughout most of 
the territory (Mayor et al. 2001). Therapeutic regimens 
for the treatment of uncomplicated P. falciparum infec-
tions were changed in 2002 to the combination of S/P + 
amodiaquine and in 2004 were further altered to S/P + 
artesunate, in line with current WHO recommendations 
for the use of ACT’s (WHO 2006). 
In Mozambique, medicinal plants play a key role 
in basic healthcare (e.g., Verzar & Petri 1987, Jansen 
& Mendes 1991). Approximately 5,500 identified plant 
species are used in traditional medicine, representing 
more than 500 plant species (WCMC 1992). 
The predominant plant species used in traditional 
medicine for the treatment of malaria infections as report-
ed by Bandeira et al. (2001) were Acacia karroo Hayne, 
Acacia nilotica, Senna abbreviata, Adansonia digitata, 
Alepidea amatymbica, Bridelia cathartica, Crossopteryx 
febrifuga, Euclea natalensis, Lippia javanica, Momordica 
balsamina, Rauwolfia caffra, Salacia kraussii, Senna oc-
cidentalis, Spirostachys africana, Tabenaemontana ele-
gans, Trichilia emetic and Zanthoxylum capense.
M. balsamina is used to cure vomiting with bile 
and fever, while S. africana is used as a therapeutic for 
headaches. R. caffra, which contains alkaloids, is used 
to treat malaria (van Wyk et al. 1997). B. cathartica is 
commonly used in southern Mozambique to heal malar-
ial headaches. In Mozambique, a mixture of eucalyptus 
leaves, avocado and guava is traditionally used to treat 
bone articulation pain associated with malaria (Kola-
wole & Adesoye 2010).
In Central Africa, C. febrifuga root and bark have 
been used as febrifuge and an antipruritic lotion, respec-
tively. In tropical Africa, the bark is used for fever, ma-
laria, diarrhoea, colic, intestinal worms and application 
to wounds. This plant is also used for the treatment of 
syphilitic ulcers and the leaves are used for eye inflam-
mation in neighbouring Tanzania (Maiga et al. 2006).
Although there is a long history of medicinal plant use 
in Mozambique, research related to the pharmacological 
evaluation and scientific validation of traditional practic-
es is still very limited, generally covering only ethnobo-
tanical aspects (e.g., Jansen & Mendes 1990, 1991).
Most studies on the pharmacological activity of 
plants used by traditional medicine in Mozambique 
have been conducted with specimens collected in other 
regions and the obtained results are only indicative be-
cause the activity of each plant depends on the region in 
which it grows or is cultivated (Table).
Results obtained by Ramalhete et al. (2008), with 
material collected in Mozambique, showed significant 
antiplasmodial activity for the ethyl acetate extract from 
aerial parts of M. balsamina (1.0 μg/mL) and for the hex-
ane extract from leaves of S. occidentalis (19.3 μg/mL). 
Another group observed that ethanol extracts from the 
leaves of S. occidentalis had high in vitro antimalarial ac-
tivity against a P. falciparum CQ-sensitive strain (< 3 μg/
mL) (Tona et al. 2004). Interesting in vitro antimalarial 
activity was also found by Jurg et al. (1991) for crude root 
ethanol and aqueous extracts and stem ethanol extract of 
B. cathartica at a concentration of 0.05 µg/mL.
Previous studies on the in vitro antimalarial activity 
of aqueous extracts of leaves and roots from S. abbre-
viata demonstrated weak activity against P. falciparum 
(Connelly et al. 1996). However, extract from leaves of 
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S. abbreviata was associated with in vivo antimalarial 
activity and these results support the traditional use of 
this species (Innocent et al. 2009). Of the other species 
of this genus, S. occidentalis is very common and wide-
ly distributed around the world. Ethanol extracts from 
leaves of this species showed a high in vitro antimalar-
ial activity (< 3 μg/mL).
The in vitro antimalarial activity of methanol and 
alkaloid-rich extracts of C. febrifuga showed this plant’s 
promise as the source of a malaria treatment (Sanon et 
al. 2003), which was confirmed in subsequent in vivo as-
says. The stem bark ethanol extract of C. febrifuga was 
investigated against malaria infections in vivo and the 
suppression of parasitaemia at the highest dose (400 mg/
kg) was similar to CQ at 5 mg/kg and pyrimethamine at 
1.2 mg/kg (Elufioye & Agbedahunsi 2004). 
Cape Verde - In Cape Verde, malaria is primarily lim-
ited to the island of Santiago, with a very low prevalence 
of approximately 20-40 cases occurring annually. Gen-
erally, transmission occurs from September-November 
(WHO 2011). Malaria has been almost eradicated from 
the archipelago of Cape Verde (West Africa) following 
a sustained control programme between 1940-1970. In 
addition, malaria is considered to be in a pre-elimination 
phase in the islands and malaria prophylaxis is not rec-
ommended for tourists.
Climatic factors and topography are particularly re-
flected in the diversity of vegetation (Gomes et al. 2008). 
Medicinal plants are notably helpful in alleviating ma-
laria symptoms such as fever, vomiting and diarrhoea.
Withania chevalieri is a shrub endemic to Cape Verde 
commonly used by local healers for malaria treatment 
(Gomes et al. 2008). Artemisia annua is one of the most 
important species used to treat malaria and several stud-
ies in search of other active compounds have been con-
ducted with species of this genus. For example, Artemi-
sia gorgonum volatile oil exhibited mild antiplasmodial 
activity in vitro (5.2 µg/mL) (Table) and this activity was 
due, at least in part, to a sesquiterpene lactone, arbores-
cin (2% in the volatile oil), which was previously report-
ed to inhibit the growth of P. falciparum. The leaves and 
flowers of A. gorgonum were investigated phytochemi-
cally and resulted in the isolation of approximately 14 
compounds. Most of these compounds exhibited mild 
antimalarial activities and a sesquiterpene lactone, ri-
dentin, was the most interesting with IC50 value of 3.8 
µg/mL against P. falciparum (Ortet et al. 2008).
Guinea-Bissau - In Guinea-Bissau, 1,575 people 
were infected with malaria in 2008 (WHO 2008). The 
prevalence of malaria in the community is low. In 1990, 
a survey of children two-nine years old in rural Guinea-
Bissau showed that P. falciparum was the most prevalent 
parasite (Jaenson et al. 1994). 
CQR P. falciparum was first reported in Guinea-
Bissau in 1990 (Hellgren et al. 1991). Since then, Plas-
modium resistance has been monitored annually and 
results have indicated stability in the level of CQR 
parasites, despite the continued widespread use of CQ 
(�rsing et al. 2007). 
In 2006, the malaria treatment policy in Guinea-Bissau 
was changed to artemether-lumefantrine as the first-line 
treatment of uncomplicated malaria. In practice, CQ is still 
used widely, with S/P as the second choice. In vivo studies 
have shown moderate but stable efficacy of CQ over the 
years (Kofoed et al. 2002, Rodrigues et al. 2008).
In 2006, a survey was conducted in Guinea-Bissau 
to contribute to the knowledge of medicinal plants of 
the country, and ethnopharmacological information on 
150 plants used as medicine was assembled. Out of these 
150 plants, Diniz et al. (2000) described 25 species with 
their vernacular names and uses in traditional medicine 
for the treatment of several diseases. In this list, only 
three medicinal plants are traditionally used in malaria 
treatment. Gomes et al. (2003) reported only six plants 
species used in ethnomedicine in Guinea-Bissau to treat 
malaria: Sarcocephalus latifolius, Lippia chevalieri, 
Guiera senegalensis, Gardenia ternifolia, Piliostigma 
thonningi and Harungana madagascariensis. Diniz et 
al. (2008) reported the use of Zanthoxylum leprieuri, 
S. latifolius and Cryptolepis sanguinolenta in malaria 
treatment. Out of the known plants used in traditional 
medicine in Guinea-Bissau, only C. sanguinolenta and 
Cochlospermum tinctorium were collected in the coun-
try and tested. There have been no studies with the other 
known medicinal plants used in Guinea-Bissau, as has 
been reported for other countries in Africa. Several 
studies were conducted with botanical species collected 
in different regions, thus preventing scientific validation 
of their use in traditional medicine in Guinea-Bissau.
Data presented below and in Table demonstrated 
the usefulness of some species as antimalarials in other 
endemic areas and the importance of testing to validate 
their traditional uses.
C. sanguinolenta is rich in indoloquinoline alka-
loids. Crytoplepine, the predominant and the most stud-
ied alkaloid, has potent in vitro antimalarial activity 
(Noamesi et al. 1991, Kirby & Paine 1995, Wright et al. 
1996, 2001, Cimanga et al. 1997) and action similar to 
CQ (Onyeibor et al. 2005).
The roots of C. tinctorium, traditionally called 
Djánderé in Guinea-Bissau (Bouquet 1968), are used 
in the treatment of liver diseases and malaria infection 
(Gomes et al. 2003). Benoit et al. (1995) performed in vitro 
assays with sensitive and resistant P. falciparum strains 
and established C. tinctorium antimalarial activity. Other 
studies of the extracts and essential oils prepared from 
leaves of this species of C. tinctorium also exhibited anti-
plasmodial activity (Benoit-Vical et al. 1999).
The indole alkaloid, strictosamide, was isolated from 
the root extract of S. latifolius and displayed moderate in 
vitro antimalarial activity against P. falciparum (Abreu 
& Pereira 2001). The evaluation of in vitro antimalarial 
activity of extracts from leaves showed that it was inac-
tive against W2 strains with an IC50 value greater than 50 
μg/mL (Gansané et al. 2010). 
G. senegalensis has been used in the treatment of 
acute gastroenteritis and dysentery and as an antimalari-
al agent (Etkins & Ross 1982, Etkins 1988). Chloroform 
extract of G. senegalensis roots exhibited pronounced 
antimalarial activity, although fractions obtained from 
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this extract did not exhibit a significant increase in anti-
malarial activity compared with the crude extract. Two 
alkaloids isolated from the active extract of G. senega-
lensis, harman and tetrahydroharman, showed antima-
larial activity (< 4 µg/mL) (Ancolio et al. 2002) and the 
latter did not present cytotoxicity and genotoxicity in the 
Salmonella Ames test (Azas et al. 2002).
An interesting in vitro synergistic antimalarial effect 
observed among compounds and extracts obtained from 
three plants commonly used as traditional remedies has 
been well demonstrated. Mitragyna inermis (total alka-
loids + ursolic acid), Nauclea latifolia (total alkaloids) 
and Feretia apodanthera (methanol fraction) together 
with G. senegalensis (harman + tetrahydroharman) in 
different associations showed synergism. These combi-
nations showed a strong and synergistic inhibitory effect 
in vitro (Azas et al. 2002). This work suggests that these 
associations can be considered good candidates for anti-
malarial combination therapy.
The leaves and stem bark of H. madagascariensis are 
used in ethnomedicine for the treatment of anaemia. The 
stem bark is also employed for nephrosis, malaria, gas-
trointestinal disorders and fever (Iwalewa et al. 2008). 
The stem bark ethanol extract showed significant anti-
malarial activity (0.517 μg/mL, CQ reference drug), thus 
indicating their positive role and justifying the use of this 
species in traditional medicine (Iwalewa et al. 2008).
The quinones bazouanthrone, harunganin, harun-
ganol A, harunganol B and the terpenes feruginin A, frie-
delan-3-one and betulinic acid have been isolated from 
the root bark of this species of H. madagascariensis and 
they have shown in vitro antimalarial activity against the 
W2 strain of P. falciparum, of which bazouanthrone (IC50 
of 1.80 mM) was the most active (Lenta et al. 2007).
STP - Malaria has long been a problem in STP, which 
stresses the health systems and hampers the economic 
development of the country (Teklehaimanot et al. 2009).
According to Martet et al. (1991), “Malaria has ex-
isted for a very long time on the archipelago. It is char-
acterised by a permanent transmission with seasonal out-
breaks that correspond with the end of the rainy season 
and the start of the dry one (April-May). Another slightly 
smaller peak occurs from November-December. Trans-
mission decreases with altitude: above 300 m of altitude 
the bio-ecology of the main vector (Anopheles gambiae) 
and the drop in the density of the human population cause 
the transmission to decline.”. Although all four species of 
Plasmodium have been detected, (Ceita 1986, Martet et 
al. 1991, Loureiro et al. 1996, Baptista et al. 1997, Lopes 
et al. 2002), P. falciparum predominates with prevalence 
rates exceeding 70% in some districts before the recent 
intensification (Pinto et al. 2000a). An. gambiae s.s. is the 
only malaria vector in the country (Pinto et al. 2000b).
In 2005, the National Centre of Endemic Diseases 
drafted a national malaria control strategy, which pro-
duced a rapid decline in malaria morbidity and mortal-
ity on the island of Príncipe. Confirmed malaria cases 
decreased from the annual average of 38,655 during 
2000-2005 to 3,893 cases in 2009 (90% decline). In the 
same period, malaria admissions fell from an annual 
average of 12,367 to 1,514 in 2009 (88% decline) and 
malaria deaths also fell from 23 to 16. However, in 2009, 
the number of confirmed malaria cases increased from 
1,647 to 3,893, a 140% increase since 2008 (WHO 2010). 
Malaria-related admissions rose from 850-950 (up 44%) 
and malaria-related deaths increased from 16 to 23 (up 
44%). The reasons for this resurgence may be linked to 
the absence of indoor residual spraying (IRS), which 
was not implemented during 2008. Once the increase in 
cases was detected by the surveillance system, emergen-
cy IRS was implemented and malaria cases decreased 
during the second half of 2009 (WHO 2010).
On these islands, a large number of medicinal plants 
have been used for centuries by traditional medicine and 
there are many places where western medicine is practi-
cally nonexistent, if not nonexistent. There are few eth-
nobotanical records of the flora of STP, and those that 
exist are quite restricted (Madureira 2008).
Roseira (2004) compiled one of the few existing ethno-
botanical records of the Santomean flora. Sequeira (1994) 
published an article about the uses of 53 medicinal plants.
Between 1993-2001, an extensive ethnopharmacol-
ogy study was conducted, collecting information on 
325 botanical species and recording more than 1,000 
ways to prepare traditional remedies and their uses 
(Madureira et al. 2002b).
Among the catalogued species, six plants represent-
ing four families were found to be commonly used in 
the treatment of malaria/fever: Morinda lucida (Ru-
biaceae), Cedrela odorata (Meliaceae), Tithonia diver-
sifolia (Asteraceae), Vernonia amygdalina (Asteraceae), 
Ageratum conyzoides (Asteraceae) and Pycnanthus an-
golensis (Myristicaceae).
Other plants, such as Leonotis nepitifolia, Struchium 
sparganophorum and Cestrum laevigatum, have also 
been reported as being commonly employed in the tradi-
tional medicine of STP. However, scientific data related 
to these species are largely nonexistent.
Madureira et al. (2002a) reported that extracts and 
fractions from S. sparganophorum have showed signifi-
cant antimalarial activity in in vitro tests and in vivo 
assays (Table).
Traditionally, the roots, stem bark and leaves of M. 
lucida are widely used in tropical Africa due to their 
reputed therapeutic value in the treatment of antipara-
sitic diseases (Kambu 1990), such as malaria (Obih et 
al. 1985, Asuzu & Chineme 1990, Agomo et al. 1992, 
Koumaglo et al. 1992, Tona et al. 1999, Bello et al. 2009). 
Investigating the antimalarial activity of this medicinal 
plant, Obih et al. (1985) reported the effect of methanol 
extracts of the stem bark, leaves and root bark against P. 
berghei in mice, where the juice from fresh leaves at a 
1:6 dilution showed a decrease in parasitaemia from the 
second day of treatment. A fraction obtained from the 
stem bark extract of this plant demonstrated antimalar-
ial activity in vivo and the highest dose produced 96.4% 
suppression of parasitaemia (Obih et al. 1985).
Phytochemical analyses revealed that M. lucida 
contains various types of alkaloids-anthraquinones and 
anthraquinols (Adewunmi & Adesogan 1984). In fact, 
Koumaglo et al. (1992) associated the antiplasmodial 
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activity of M. lucida stem bark and root to the presence 
of the anthraquinones digitolutein, rubiadin-1-methyl-
ether and damnacanthal. 
C. odorata is considered one of the most valuable for-
est tree species in the tropics and is also one of the most 
widely distributed (Millán-Orozco et al. 2011). In the 
tropics, species of the Meliaceae family are extensively 
used as traditional medicine against malaria (Khalid et 
al. 1986, Phillipson & Wright 1991, Leaman et al. 1995) 
and fevers (Ayensu et al. 1981), a characteristic symptom 
of malaria. In Africa, the decoction of C. odorata barks is 
used against this disease (Madureira 2008) and antima-
larial activity of some compounds in bark and leaves was 
reported (MacKinnon et al. 1997, Omer et al. 2003).
In work by MacKinnon et al. (1997), extracts of 22 spe-
cies of Meliaceae, including C. odorata, were examined 
for their antimalarial activity using in vitro tests with two 
clones of P. falciparum, one sensitive to CQ (W2) and one 
CQR (D6). The ethanol extract of C. odorata wood ex-
hibited the highest activity against both clones, with IC50 
values of 1.25 µg/mL (D6) and 1.37 µg/mL (W2). This 
activity was associated with the presence of tetranortriter-
penoids (limonoids), a class of compounds characteristic 
of the Meliaceae family (MacKinnon et al. 1997).
A member of the family Asteraceae, T. diversifolia, 
is widely used for the treatment of malaria in STP (Elu-
fioye & Agbedahunsi 2004, Owoyele et al. 2004, Mo-
ronkola et al. 2007).
The importance of this species as an antimalarial has 
been documented by many authors who found activity 
for the nonpolar and medium polarity extracts (Goffin 
et al. 2002, Madureira et al. 2002a, Elufioye & Agbeda-
hunsi 2004). 
As expected for a member of Asteraceae family, this 
species contains sesquiterpene lactones tagitinin A-C 
and F. Tagitinin C was reported as an active antiplas-
modial component (0.33 µg/mL), which also possessed 
cytotoxic properties (IC50 on HTC-116 cells: 0.706 µg/
mL) (Goffin et al. 2002).
V. amygdalina, from the Asteraceae family, is com-
monly known as “bitter leaf” and often appears in tra-
ditional medicines in Africa. Acetone-water and ethanol 
extracts of the leaves showed crescent antiplasmodial ac-
tivity (Masaba 2000, Madureira et al. 2002a, Iwalokun 
2008). In addition, this species achieved special rele-
vance, having been shown to possess potent antimalarial 
activity in human medicine (Abosi & Roseroka 2003).
Other pharmacological studies of V. amygdalina have 
demonstrated the inherent ability of aqueous leaf extract 
to assist the restoration of CQ efficacy as a prophylactic 
and chemotherapeutic agent against CQ-sensitive and 
resistant P. berghei infection in mice (Iwalokun 2008).
Also belonging to the Asteraceae family, preliminary 
evaluation of the antimalarial activity of A. conyzoides 
demonstrated that the aqueous extract of leaves exhibit-
ed dose-dependent activity in infected mice. At the dose 
of 400 mg/kg, this extract produced chemosuppression 
of 89.87%, which is higher than that of CQ (83.12%) at 
5 mg/kg, indicating high antimalarial potential (�kwe 
et al. 2010). It was also reported that non-polar extract of 
the leaves has moderate in vitro antiplasmodial activity 
(12.08 μg/mL) (Chenniappan & Kadarkarai 2010).
Dichloromethane, methanol and aqueous ethanol 
extracts of P. angolensis barks were evaluated for 
their in vitro antimalarial activity and dichlorometh-
ane extract was the most effective (IC50 of 1.6 μg/mL) 
(Abrantes et al. 2008).
Angola - Malaria is the leading cause of morbidity 
and mortality in Angola. According to the National Ma-
laria Control Programme, four million clinical cases and 
20,000 deaths were reported in 2005, accounting for 35% 
of the overall mortality in children under five and 25% 
of maternal deaths (WHO 2005). Malaria is endemic in 
most areas of the Angolan territory, with P. falciparum 
as the predominant infecting species (WHO 2005). The 
epidemiological characteristics of malaria in Angola 
vary from hyper-endemic (northern and north-eastern of 
the country) to mesoendemic stable and mesoendemic 
unstable (Menegon et al. 2009). 
Angola is rich in many medicinal plants whose po-
tential has yet to be explored. However, there is some 
information about medicinal plants in this country and 
their uses for the treatment of malaria. The primary 
species associated with disease treatment are Artemisia 
afra, Gardenia jovis-tonantis, V. amygdalina, Conysa 
welwitschii, Lantana camara, Harungana madagas-
carensis, Psorosperum febrifugum, Paveta schuman-
niana, Crassocephalum rubens, Crassocephalum mul-
ticorymbosum and Cajanus cajan (Van-Dúnem 1994, 
Bossard 1996).
Bridelia ferruginea is a shrub found in northern An-
gola that is popularly used to treat malaria. Kolawole & 
Adesoye (2010) conducted a study to evaluate the anti-
malarial activity of this species with a sensitive strain of 
P. berghei (Table). An extract of Cochlospermum ango-
lense root, popularly used in Angola for the prophylaxis 
of malaria, exhibited in vitro activity against P. falci-
parum (50 μg/mL) (Presber et al. 1992).
Piper umbellatum is common species in Angola, 
Mozambique and Brazil, especially in the Amazon Re-
gion. This plant has been used to treat malaria and there 
has been a study describing the active compound of this 
species (de Andrade-Neto et al. 2008).
Another widespread species, V. amygdalina, is also 
used to treat malaria in Angola and recent in vivo stud-
ies carried out in Nigeria have shown the effectiveness of 
this species (Iwalokun 2008). 
The stem bark essential oil of Hexalobus crispiflo-
rus, characterised by high sesquiterpene content (99.5%), 
showed high activity against P. falciparum (2.0 μg/mL). 
Another species, Pachypodanthium confine, whose stem 
bark essential oil has lower amounts of sesquiterpenes 
(88%), was also assayed against the same strains. Results 
showed that the activity (16.5 μg/mL) was lower than that 
observed for H. crispiflorus essential oil. The authors 
suggested that the sequiterpene content could be respon-
sible for the antimalarial properties (Boyom et al. 2003).
Correlation among genera from the CPSC, extracts 
and antimalarial active chemical classes - Fig. 2 shows 
thatterpenes and alkaloids are the dominant classes of 
substances with antimalarial activity found in the stud-
ied extracts. Active terpenes were found in hydrophilic 
and lipophilic extracts from twelve genera (Cecropia, 
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Cedrela, Hexalobus, Pothomorphe, Artemisia, Scopa-
ria, Pachypodantium, Tithonia, Piper, Virola, Picrolem-
ma and Ocimum). Active alkaloids were found in eight 
genera (Abuta, Esenbeckia, Guiera, Aspidosperma, 
Harungana, Sarcocephalus, Geissospermum and Cryp-
tolepsis), the majority of which were obtained from alco-
hol or crude alkaloid extracts. Phenolics, from lipophilic 
extracts of Andira and Harungana, and steroids, from 
extracts of Cecropia, Vernonia, Harungana and Mo-
mordica, are additional active antimalarial classes that 
have been previously studied (Fig. 2).
Final considerations - Of the countries covered in 
this review, Brazil had the largest number of native 
species studied and active substances identified for the 
treatment of malaria parasites. The ethnopharmacologi-
cal work in STP resulted in important surveys about me-
dicinal plants popularly used in the region. It is important 
to emphasise that many of the studies using the African 
species were not performed at the place of their harvest, 
which can lead to changes in chemical composition with 
probable alterations to therapeutic action.
Regarding common use among the CPSC, Brazil and 
Mozambique share the common use of species from the 
botanical Fabaceae and Cucurbitaceae families. Among 
Fabaceae species, S. occidentalis is employed to treat 
malaria in both countries. Within the Cucurbitaceae 
family, there are reports on the common use of two taxa, 
Cucurbita maxima and M. balsamina.
In Brazil and STP, three botanical species distributed 
among the Myristicaceae and Meliaceae families have 
ethnopharmacological uses for malaria treatment and 
studies have corroborated their pharmacological activ-
ity against P. falciparum. In this context, two species of 
Myristicaceae, V. surinamensis and P. angolensis, occur 
in ecosystems in Brazil and Africa, respectively. The 
decoction of C. odorata bark of the Meliaceae family is 
popularly used in the same manner in both countries.
Eight botanical species of the Asteraceae family are 
distributed within four countries of the CPSC: three in 
Brazil (A. australe, B. pilosa and V. brasiliana), three in 
STP (A. conyzoides, S. sparganophorum and T. diversi-
folia) and one in Cape Verde (A. gorgonum). V. amyg-
dalina is a commonly used botanical species in Angola 
and STP. The Piperaceae family is represented by two 
plant species, Pothomorphe peltata (Brazil) and P. um-
bellatum (Angola, Brazil and Mozambique), which are 
both employed to treat malaria.
There is a wide biodiversity in these countries that 
has not yet been thoroughly explored that represents a 
treasure of useful information in the search for antima-
larials or treatments for other diseases. 
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